Literature DB >> 2228803

The ototoxic mechanism of cisplatin.

D McAlpine1, B M Johnstone.   

Abstract

The ototoxic mechanism of cisplatin was investigated. Potentiation of cisplatin ototoxicity by furosemide and amino-oxyacetic acid (AOAA) was observed. Substantial hearing loss in cisplatin-deafened animals was accompanied by normal values of the endocochlear potential and a reduction in the sensitivity of the 2f1-f2 distortion products. The loss in dB of the sensitivity of the distortion products correlated extremely well with the loss of the neural sensitivity in dB. There was also a relationship between the fractional reduction of the low frequency (1000 Hz) microphonic potential and hearing loss in dB. Iontophoresis of cisplatin into scala media resulting in the immediate loss of neural thresholds at the site of iontophoresis. It is concluded that cisplatin caused the hearing loss by blocking OHC transduction channels.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2228803     DOI: 10.1016/0378-5955(90)90151-e

Source DB:  PubMed          Journal:  Hear Res        ISSN: 0378-5955            Impact factor:   3.208


  23 in total

Review 1.  Drug-induced tinnitus and other hearing disorders.

Authors:  H Seligmann; L Podoshin; J Ben-David; M Fradis; M Goldsher
Journal:  Drug Saf       Date:  1996-03       Impact factor: 5.606

2.  Cisplatin ototoxicity and otoprotection with sodium salicylate.

Authors:  Miguel Angelo Hyppolito; José Antonio A de Oliveira; Maria Rossato
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-06-07       Impact factor: 2.503

3.  Detection of cisplatin-induced ototoxicity with transient evoked otoacoustic emission test before pure tone audiometer.

Authors:  Süleyman Yilmaz; Fatih Oktem; Emin Karaman
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-11-28       Impact factor: 2.503

Review 4.  Aminoglycoside- and Cisplatin-Induced Ototoxicity: Mechanisms and Otoprotective Strategies.

Authors:  Corné J Kros; Peter S Steyger
Journal:  Cold Spring Harb Perspect Med       Date:  2019-11-01       Impact factor: 6.915

5.  Acute hyperpolarization and elongation of cochlear outer hair cells on superfusion with cis-platinum.

Authors:  A Ernst; H P Zenner
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503

6.  Application of a neuroprotective ACTH(4-9) analog to affect cisplatin ototoxicity: an electrocochleographic study in guinea pigs.

Authors:  F P Hamers; S F Klis; W H Gispen; G F Smoorenburg
Journal:  Eur Arch Otorhinolaryngol       Date:  1994       Impact factor: 2.503

7.  Evidence that cisplatin-induced auditory damage is attenuated by downregulation of pro-inflammatory cytokines via Nrf2/HO-1.

Authors:  HongSeob So; HyungJin Kim; Yunha Kim; Eunsook Kim; Hyun-Ock Pae; Hun-Taeg Chung; Hye-Jung Kim; Kang-Beom Kwon; Kang-Min Lee; Haa-Yung Lee; Sung-Kyun Moon; Raekil Park
Journal:  J Assoc Res Otolaryngol       Date:  2008-06-27

Review 8.  Auditory and vestibular functions after single or combined exposure to toluene: a review.

Authors:  T C Morata; P Nylén; A C Johnson; D E Dunn
Journal:  Arch Toxicol       Date:  1995       Impact factor: 5.153

Review 9.  Experimental, clinical and preventive aspects of ototoxicity.

Authors:  A A Chiodo; P W Alberti
Journal:  Eur Arch Otorhinolaryngol       Date:  1994       Impact factor: 2.503

Review 10.  Comparative adverse effect profiles of platinum drugs.

Authors:  M J McKeage
Journal:  Drug Saf       Date:  1995-10       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.